About Disc Medicine
Disc Medicine is a company based in Cambridge (United States) founded in 2017 by Brian Mac Donald.. Disc Medicine has raised $140 million across 4 funding rounds from investors including ARE, Orbimed and Janus Henderson Investors. The company has 84 employees as of December 31, 2024. Disc Medicine offers products and services including Bitopertin, DISC-0974, and DISC-3405. Disc Medicine operates in a competitive market with competitors including Freeline, Keros Therapeutics, Jasper Therapeutics, Interius Biotherapeutics and China Biologic Products Holdings, among others.
- Headquarter Cambridge, United States
- Employees 84 as on 31 Dec, 2024
- Founders Brian Mac Donald
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Disc Medicine, Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-109.36 M-43.08as on Dec 31, 2024
-
EBITDA
$-129.56 M-42.34as on Dec 31, 2024
-
Total Equity Funding
$140 M (USD)
in 4 rounds
-
Latest Funding Round
$62.5 M (USD), Post-IPO
Feb 14, 2023
-
Investors
ARE
& 11 more
-
Employee Count
84
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Disc Medicine
Disc Medicine is a publicly listed company on the NASDAQ with ticker symbol IRON in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Disc Medicine
Disc Medicine offers a comprehensive portfolio of products and services, including Bitopertin, DISC-0974, and DISC-3405. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Drug for treating erythropoietic protoporphyria by reducing PPIX levels
Candidate for hematologic diseases through targeted development
Therapy in development for blood disorder applications
Unlock access to complete
Unlock access to complete
Funding Insights of Disc Medicine
Disc Medicine has successfully raised a total of $140M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $62.5 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Post-IPO — $62.5M
- First Round First Round
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2023 | Amount | Post-IPO - Disc Medicine | Valuation | Bain Capital Life Sciences | |
| Sep, 2021 | Amount | Series B - Disc Medicine | Valuation | Orbimed | |
| Oct, 2019 | Amount | Series A - Disc Medicine | Valuation | Novo Holdings |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Disc Medicine
Disc Medicine has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, Orbimed and Janus Henderson Investors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are focused on pharmaceutical, biotechnology, and medical sectors.
|
Founded Year | Domain | Location | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Investment and holding company controlled by Len Blavatnik
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Disc Medicine
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Disc Medicine
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Disc Medicine Comparisons
Competitors of Disc Medicine
Disc Medicine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Freeline, Keros Therapeutics, Jasper Therapeutics, Interius Biotherapeutics and China Biologic Products Holdings, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Gene therapy platform is developed for chronic disease treatments.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed to treat hematologic and musculoskeletal disorders.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for chronic diseases by targeting mast cells and stem cells
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating multiple diseases
|
|
| domain | founded_year | HQ Location |
Human plasma-based biopharmaceutical products are developed and commercialized.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Disc Medicine
Frequently Asked Questions about Disc Medicine
When was Disc Medicine founded?
Disc Medicine was founded in 2017.
Where is Disc Medicine located?
Disc Medicine is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Who is the current CEO of Disc Medicine?
Brian Mac Donald is the current CEO of Disc Medicine. They have also founded this company.
Is Disc Medicine a funded company?
Disc Medicine is a funded company, having raised a total of $140M across 4 funding rounds to date. The company's 1st funding round was a Series A of $50M, raised on Jun 01, 2017.
How many employees does Disc Medicine have?
As of Dec 31, 2024, the latest employee count at Disc Medicine is 84.
What does Disc Medicine do?
Disc Medicine was founded in 2017 and is headquartered in Cambridge, United States. Focus is placed on developing therapeutic candidates that target fundamental pathways in red blood cell biology to address hematologic diseases. The product pipeline features Bitopertin, intended for erythropoietic porphyrias; DISC-0974, aimed at anemia associated with myelofibrosis; and matriptase-2, designed for myelodysplastic syndromes. Operations center on advancing these candidates through clinical development in the biotechnology sector.
Who are the top competitors of Disc Medicine?
Disc Medicine's top competitors include Keros Therapeutics, Freeline and Jasper Therapeutics.
What products or services does Disc Medicine offer?
Disc Medicine offers Bitopertin, DISC-0974, and DISC-3405.
Is Disc Medicine publicly traded?
Yes, Disc Medicine is publicly traded on NASDAQ under the ticker symbol IRON.
Who are Disc Medicine's investors?
Disc Medicine has 12 investors. Key investors include ARE, Orbimed, Janus Henderson Investors, Atlas Venture, and Arix Bioscience.
What is Disc Medicine's ticker symbol?
The ticker symbol of Disc Medicine is IRON on NASDAQ.